Understanding the genetics behind Lyme arthritis severity
Molecular Genetics of Lyme Arthritis
This study is looking at how our genes might affect how bad Lyme arthritis can get, using mice to find out which specific genes are linked to different levels of the disease, so we can better understand why some people have worse symptoms than others and improve treatments in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10754232 on NIH RePORTER |
What this research studies
This research investigates how genetic factors influence the severity of Lyme arthritis, a condition caused by the Borrelia burgdorferi bacteria. By studying different mouse models that exhibit varying levels of arthritis, researchers aim to identify specific genes that contribute to these differences. The approach involves advanced genetic mapping techniques to pinpoint alleles associated with the severity of symptoms. This could lead to a better understanding of how Lyme disease affects individuals differently and inform future treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Lyme disease who are experiencing varying degrees of arthritis symptoms.
Not a fit: Patients who do not have Lyme disease or those without arthritis symptoms are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to personalized treatment options for patients suffering from Lyme arthritis based on their genetic profiles.
How similar studies have performed: Previous research has shown promise in understanding genetic influences on disease severity, suggesting that this approach could yield valuable insights.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Weis, Janis J. — University of Utah
- Study coordinator: Weis, Janis J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.